| Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
|---|
| 06/19/2008 | CA2672338A1 Archaeal polar lipid aggregates for administration to animals |
| 06/19/2008 | CA2672215A1 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 06/19/2008 | CA2672055A1 Treatment of cachexia |
| 06/19/2008 | CA2672049A1 Monoclonal antibodies against angptl3 |
| 06/19/2008 | CA2672026A1 Salmonella vaccine |
| 06/19/2008 | CA2671971A1 Urokinase-type plasminogen activator receptor epitope, monoclonal antibodies derived therefrom and methods of use thereof |
| 06/19/2008 | CA2671968A1 Abeta antibody parenteral formulation |
| 06/19/2008 | CA2671724A1 Alpha b-crystallin as a therapy for inflammation |
| 06/19/2008 | CA2670707A1 Compositions and methods for treating a neoplasm |
| 06/19/2008 | CA2660038A1 Hemagglutinin polypeptides, and reagents and methods relating thereto |
| 06/18/2008 | EP1932926A2 Method of diagnosing ovarian endometriosis |
| 06/18/2008 | EP1932915A2 Materials and methods relating to improved vaccination strategies |
| 06/18/2008 | EP1932914A2 Caspase-9 deficient animals and the use thereof |
| 06/18/2008 | EP1932911A1 Promoter for introducing gene into lymphocyte or blood cell and application thereof |
| 06/18/2008 | EP1932857A1 Preventive/remedy for cancer |
| 06/18/2008 | EP1932856A2 IL-8 inhibitors |
| 06/18/2008 | EP1932540A1 SECRETORY IgA AND IgG ANTIBODIES-INDUCING AGENT |
| 06/18/2008 | EP1932539A2 Signal-1/Signal-2 bifunctional peptide inhibitors |
| 06/18/2008 | EP1932538A1 Biodegradable nanoparticle having t-cell recognizable epitope peptide immobilized thereon or encapsulated therein |
| 06/18/2008 | EP1932537A1 Expression of transgenic T cell receptors in LAK-T cells |
| 06/18/2008 | EP1931710A2 Engineered anti-il-23 antibodies |
| 06/18/2008 | EP1931700A1 FUNCTIONAL EPITOPES OF STREPTOCOCCUS PNEUMONIAE PsaA ANTIGEN AND USES THEREOF |
| 06/18/2008 | EP1931390A2 Compositions and methods for treatment of autoimmune disease |
| 06/18/2008 | EP1931385A2 (s)-6-methyloxaalkyl exemestane compounds and related methods of use |
| 06/18/2008 | EP1931384A2 Manipulation of regulatory t cell and dc function by targeting neuritin gene using antibodies, agonists and antagonists |
| 06/18/2008 | EP1931383A1 Interleukin-1 conjugates and uses thereof |
| 06/18/2008 | EP1931382A2 Ancestral dengue virus envelope protein sequence |
| 06/18/2008 | EP1931381A2 Immunogenic agents |
| 06/18/2008 | EP1931380A2 Multiple vaccination including serogroup c meningococcus |
| 06/18/2008 | EP1931379A2 Proteins with improved solubility and methods for producing and using same |
| 06/18/2008 | EP1931378A2 Stabilized virus-like particles and epitope display systems |
| 06/18/2008 | EP1931377A1 Cd4+ t survivin epitopes and uses thereof |
| 06/18/2008 | EP1931376A2 Compositions and methods for treating tumors presenting survivin antigens |
| 06/18/2008 | EP1931375A2 Chemo-immunotherapy method |
| 06/18/2008 | EP1931343A2 Methods using 3-(4-amino-1-oxo-1,3-dihydro-isoindol-2-yl)-piperidine-2,6-dione for treatment of certain leukemias |
| 06/18/2008 | EP1931331A1 Combinations comprising dmxaa for the treatment of cancer |
| 06/18/2008 | EP1931311A1 Polysaccharide microparticles containing biological agents: there preparation and applications |
| 06/18/2008 | EP1727562B1 Method of vaccination against testicular bvdv infection |
| 06/18/2008 | EP1685243B1 Immortalized avian cell lines for virus production |
| 06/18/2008 | EP1385541B1 Immunostimulant compositions comprising an aminoalkyl glucosaminide phosphate and qs-21 |
| 06/18/2008 | EP1372708B1 Vaccine for transcutaneous immunization against travellers' diarrhoea |
| 06/18/2008 | EP1343895B1 Streptococcus pyogenes antigens and corresponding dna fragments |
| 06/18/2008 | EP1257648B1 Antagonistic selective binding agents of osteoprotegerin binding protein |
| 06/18/2008 | EP1228203B1 Peptide (virip) which inhibits a circulating virus in humans and the use thereof |
| 06/18/2008 | EP1198479B1 Neovascular-targeted immunoconjugates |
| 06/18/2008 | EP1115746B1 Antibodies to mammalian langerhans cell antigen and their uses |
| 06/18/2008 | EP1064027B1 Apo-2 ligand-anti-her-2 antibody synergism |
| 06/18/2008 | EP0918541B9 Immunstimulating lipid formulation |
| 06/18/2008 | CN101203607A Anti-CD-20 monoclonal antibody |
| 06/18/2008 | CN101203605A Deacylation of lps in gram negative bacteria |
| 06/18/2008 | CN101203532A Antibodies against candida antigens |
| 06/18/2008 | CN101203529A Proteins and nucleic acids from meningitis/sepsis-associated escherichia coli |
| 06/18/2008 | CN101203242A Method for treating dementia or alzheimer's disease by CD2O antibody |
| 06/18/2008 | CN101203241A Humanized anti-CD70 binding agents and uses thereof |
| 06/18/2008 | CN101203240A Recombinant flavivirus vaccines |
| 06/18/2008 | CN101203239A Methods and means for diagnostics, prevention and treatment of mycobacterium infections and tuberculosis disease |
| 06/18/2008 | CN101200710A Duck plague vaccines and special strains therefor |
| 06/18/2008 | CN101200708A Mouse anti-human CD14 monoclonal antibody hybridoma cell line, monoclonal antibody, immunohistochemical reagent kit and uses thereof |
| 06/18/2008 | CN101199861A DNA vaccine for anti-liver cancer |
| 06/18/2008 | CN101199845A Stable anti-IgE humanized single anti-agent |
| 06/18/2008 | CN101199844A Liquid agent of stable anti-EGFR chimeric antibody |
| 06/18/2008 | CN101199843A Whooping cough genetic engineering blending second unit vaccine and preparing method thereof |
| 06/18/2008 | CN101199483A Stable anti-HER2 humanized antibody preparation |
| 06/18/2008 | CN100395342C Recombinant Ag85B-Rv3425 bacillus Calmette-Guerin vaccine |
| 06/18/2008 | CN100395339C Method for expressing hepatitis C virus envelope protein E2 by mammal cell with high efficient secretion |
| 06/18/2008 | CN100394984C Bivalent DNA vaccine for Japanese blood fluke and preparation process thereof |
| 06/18/2008 | CA2571348A1 Anti-tumour immunity and specific t cell memory are induced by low dose inoculation with nonreplicating recombinant adenovirus encoding tap1 |
| 06/17/2008 | US7388089 Anti-arthropod vector vaccines method of selecting and uses thereof |
| 06/17/2008 | US7388087 Enhancement of immune response to vaccine by interferon alpha |
| 06/17/2008 | US7388080 Monoclonal antibody for use in treatment and prevention of pathogen infection |
| 06/17/2008 | US7388078 Nucleic acids encoding polypeptides having chips activity |
| 06/17/2008 | US7388071 Telomerase peptide is modified to enhance binding to a major histocompatibility complex (MHC) molecule |
| 06/17/2008 | US7387900 Colloidal metal compositions and methods |
| 06/17/2008 | US7387897 Tetrameric antibody complexes for blocking non-specific labeling of antigens |
| 06/17/2008 | US7387894 replication-defective recombinant adenovirus comprising a heterologous nucleic acid sequence encoding an antigenic determinant of Plasmodium falciparum; ntigenic determinant comprises an immunogenic peptide of the circumsporozoite protein; viral vectors |
| 06/17/2008 | US7387886 Prion protein dimers useful for vaccination |
| 06/17/2008 | US7387882 Predictive assay for immune response |
| 06/17/2008 | US7387881 Marking using antigen; detecting cancer |
| 06/17/2008 | US7387873 Human myeloma cell line |
| 06/17/2008 | US7387791 Oral administering; tablet with enteric coating; supplying drug to gastrointestinal systems |
| 06/17/2008 | US7387782 Protein kinase deficient, immunologically active CMVpp65 mutants |
| 06/17/2008 | US7387779 Anti-angiogenic proteins and fragments and methods of use thereof |
| 06/17/2008 | US7387778 Therapeutic methods and compositions for the treatment of impaired interpersonal and behavioral disorders |
| 06/17/2008 | US7387777 Methods of treating hemophilia or von willebrand disease with p-selectin |
| 06/17/2008 | US7387776 Human monoclonal antibodies against CD30 |
| 06/17/2008 | US7387773 Vaccine |
| 06/17/2008 | US7387772 or immunoreactive fragment thereof that binds to the Mu-9 epitope of a colon-specific antigen-p mucin (CSAp) antigen; binds target tissue and conjugate carrying epitope (haptens)l; immunoconjugate; fusion proteins; colon cancer |
| 06/17/2008 | US7387271 Immunostimulatory combinations |
| 06/17/2008 | CA2274852C Method of coupling polysaccharides to proteins |
| 06/17/2008 | CA2247336C Parapoxviruses containing foreign dna, their production and their use in vaccines |
| 06/17/2008 | CA2189051C Composition for delivery of toxic radioisotopes to the cell nucleus and use |
| 06/17/2008 | CA2183888C Antibody purification |
| 06/17/2008 | CA2177667C Mammalian vaccine compositions comprising squalene or squalane, lecithin and a polyoxyethylene sorbitan ester as an adjuvant |
| 06/17/2008 | CA2117193C Vaccine comprising part of constant region of ige for treatment of ige-medicated allergic reactions |
| 06/17/2008 | CA2067250C Inhibition of padgem-mediated cell binding |
| 06/17/2008 | CA1341574C Plasmid for production of membrane protein, bacterium containing same, monoclonal antibody therefore, and method for the idenification of haemophilus influenzae |
| 06/12/2008 | WO2008070780A1 Antagonist antibodies against ephb3 |
| 06/12/2008 | WO2008070616A2 METHODS AND COMPOSITIONS RELATED TO HIF-1α |
| 06/12/2008 | WO2008070593A2 Variant target binding agents and uses thereof |
| 06/12/2008 | WO2008070363A2 Intrabodies |